Home infection
 

Keywords :   


Tag: infection

Survey Shows Brachyspira Infection Gradually Increasing

2013-05-22 02:00:00| ThePigSite - Industry News

CANADA - The latest Canadian Swine Health Intelligence Network survey of Canadian swine veterinarians shows the number of farms across the prairies infected by swine dysentery caused by Brachyspira appears to be gradually increasing, writes Bruce Cochrane.

Tags: shows survey increasing infection

 

In Animal Model Of Hepatitis B Infection, New Drug Stimulates Immune System To Kill Infected Cells

2013-04-30 12:01:53| Biotech - Topix.net

A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.

Tags: to system model drug

 
 

New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection

2013-04-27 21:23:10| Biotech - Topix.net

In a study conducted at Texas Biomed's Southwest National Primate Research Center, researchers found that the immune modulator GS-9620, which targets a receptor on immune cells, reduced both the virus levels and the number of infected liver cells in chimpanzees chronically infected with hepatitis B virus .

Tags: system model drug cells

 

Merck to Present Updated Interim Data from Phase II Trial Evaluating Investigational NS3/4A Protease Inhibitor MK-5172 for Chronic Hepatitis C Virus Genotype 1 Infection at the International Liver Congress

2013-04-23 12:00:00| Merck.com - Research & Development News

Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection. MK-5172 is an investigational, once-daily, oral HCV NS3/4A protease inhibitor that in preclinical evaluations has demonstrated a high barrier to resistance. Language:  English Contact HTML:  MerckMedia Contact:Caroline Lappetito, 267-305-7639orInvestor Contacts:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: the data international updated

 

The great medical imitator: a case of syphilitic osteitis in the setting of HIV infection

2013-04-05 10:25:39| Footwear - Topix.net

Janine M. Trevillyan A D , Kenneth S. Yap B and Jennifer Hoy A C A Infectious Diseases Unit, The Alfred Hospital, Melbourne, Vic.

Tags: of great case medical

 

Sites : [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »